Related Experiment Video
Updated: Dec 12, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer
Jing Wu1, Zuojun Shen1,2
1Department of Clinical Laboratory, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui, P.R. China.
Abstract:
More and more studies report that exosomes released by various cells can serve as a medium for information exchange between different cells. Through a deep understanding of the physical and chemical properties of exosomes, the researchers revealed a more precise molecular mechanism of its participation in the process of intercellular communication. In particular, microRNA (miRNA) is found inside exosomes, as well as long noncoding RNA (lncRNA). Extensive evidence indicates that exosomal miRNAs participates in the occurrence and development of lung cancer and plays a variety of roles. Therefore, the release of RNA-containing exosomes in many different kinds of body fluids has caused widespread interest among researchers. In this review, we report evidence from human studies involving miRNAs and other ncRNAs in exosomes associated with lung cancer as diagnostic and prognostic markers. Currently, there is a small amount of evidence that exosomal miRNAs can be used as early diagnosis and prognostic markers for lung cancer, and their exact role in lung cancer patients still needs further study.
Insights
Exosomes carrying microRNAs (miRNAs) and other noncoding RNAs (ncRNAs) show potential as lung cancer biomarkers. Further research is needed to confirm their diagnostic and prognostic value in patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Exosomes facilitate intercellular communication by transferring molecules like microRNA (miRNA) and long noncoding RNA (lncRNA).
- These exosomal RNAs are increasingly implicated in the development and progression of lung cancer.
- The presence of RNA-containing exosomes in body fluids has spurred interest in their clinical applications.
Purpose of the Study:
- To review current evidence on exosomal miRNAs and other ncRNAs as diagnostic and prognostic markers for lung cancer.
- To highlight the role of exosomal RNAs in lung cancer pathogenesis and intercellular communication.
Main Methods:
- Review of human studies focusing on exosomal miRNAs and ncRNAs in lung cancer.
- Analysis of existing data regarding the diagnostic and prognostic potential of these biomarkers.
Main Results:
- Exosomal miRNAs and ncRNAs are present in various body fluids.
- Preliminary evidence suggests exosomal miRNAs can serve as early diagnostic and prognostic indicators for lung cancer.
- The precise roles and clinical utility require further investigation.
Conclusions:
- Exosomal RNAs represent a promising, minimally invasive source for lung cancer biomarkers.
- Additional research is essential to validate exosomal miRNAs and ncRNAs for clinical use in lung cancer diagnosis and prognosis.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

